Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01502787 · ClinicalTrials.gov registry record · Phase 4
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT01502787 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 46 participants.
The verdict
NCT01502787, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Nebivolol a) attenuates the angiotensin II (Ang II)-induced increase in oxidative stress, thereby attenuating Ang II-induced vasoconstriction; and b) attenuates sympathetic mediated vasoconstriction during exercise, thereby reducing functional skeletal muscle ischemia in hypertensive patients.
Interventions
- DRUG Nebivolol
- DRUG Metoprolol succinate
- PROCEDURE Microneurography
- PROCEDURE Rhythmic handgrip exercise
- PROCEDURE Forearm blood flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2009-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01502787
The ClinicalTrials.gov registry entry for NCT01502787 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Nebivolol is the first listed.
NCT01502787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01502787 about?
NCT01502787 is a clinical study titled "Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients". The purpose of this study is to determine if Nebivolol a) attenuates the angiotensin II (Ang II)-induced increase in oxidative stress, thereby attenuating Ang II-induced vasoconstriction; and b) attenuates sympathetic mediated vasoconstriction during exercise, thereby reducing functional skeletal mu...
What is the current status of trial NCT01502787?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2009-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01502787?
The interventions under investigation include: Nebivolol (DRUG), Metoprolol succinate (DRUG), Microneurography (PROCEDURE), Rhythmic handgrip exercise (PROCEDURE), Forearm blood flow (PROCEDURE).
Who is sponsoring clinical trial NCT01502787?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.